The Leukemia & Lymphoma Society is leading the offensive against acute myeloid leukemia. Beat AML is a groundbreaking Master Trial for patients with acute myeloid leukemia (AML). The Leukemia & Lymphoma Society (LLS) is leading a multi-institutional collaborative clinical trial to increase understanding of the underlying causes of AML and develop more effective therapies to treat patients. Enroll your newly diagnosed AML patients in a clinical trial today. Contact an Information Specialist 800.955.4572 or visit www.lls.org/beat-aml Thanks to the American Society of Hematology for its support in raising awareness and providing education about this critical initiative.http://www.lls.org/beat-aml